Symptomatic Acute Pancreatitis Induced by Nilotinib: A Report of Two Cases

Nilotinib is a selective tyrosine kinase inhibitor for the treatment of Philadelphia chromosome-positive leukemias. An elevation of the pancreatic enzyme level is one of the major adverse events associated with nilotinib, but whether or not nilotinib induces symptomatic pancreatitis remains to be el...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamada, Toshiki, Nannya, Yasuhito, Shimizu, Masahito, Seishima, Mitsuru, Tsurumi, Hisashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216150/
https://www.ncbi.nlm.nih.gov/pubmed/27904116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216150/
https://www.ncbi.nlm.nih.gov/pubmed/27904116

Ejemplares similares